Audrey Kunin - Sep 14, 2022 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Chief Product Officer, Director
Signature
/s/ Audrey Kunin
Stock symbol
NBY
Transactions as of
Sep 14, 2022
Transactions value $
-$46,094
Form type
4
Date filed
9/16/2022, 06:24 PM
Previous filing
Dec 7, 2021
Next filing
Dec 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBY Common Stock Sale -$46.1K -291K -58.27% $0.16 209K Sep 14, 2022 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $0.1565 to $0.1605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.